Astronics Reports Strong Q1 Results, Convertible Notes Now Convertible
ATRO has more than doubled off its 52-week low of $27.27 on elevated volume (2.1× avg).
Summary
Astronics reported strong Q1 2026 financial results, including significant sales and net income growth, but also disclosed that its convertible notes have met conversion triggers, posing a potential dilution risk.
Key Events · Earnings and Guidance · ATRO
-
Strong Q1 2026 Financial Performance
Sales increased 12% to $230.6 million, and net income surged 168% to $25.5 million, resulting in diluted EPS of $0.67. These figures were previously announced via an 8-K and news on May 12, 2026.
-
Convertible Notes Conversion Triggered
Both the 2030 and 2031 convertible notes met stock price conditions, allowing holders to convert. No 2031 notes were converted in Q1, but 2030 notes are convertible in Q2 2026, posing a potential for future dilution.
-
Robust Backlog and Book-to-Bill
Backlog grew to $734.3 million at quarter-end, with a strong book-to-bill ratio of 1.26:1 for the quarter, indicating solid future revenue visibility.
-
Increased Capital Expenditures
Cash used in investing activities rose significantly to $11.2 million, primarily for catch-up investments and the consolidation of operations into a new Seattle facility.
Analysis · ATRO · Manufacturing
This 10-Q provides the full financial details for the strong first quarter of 2026, which saw significant increases in sales and net income. While the headline earnings figures were previously announced, the filing reveals that both the 2030 and 2031 convertible notes met their respective stock price triggers, allowing holders to convert. This introduces a material potential for dilution, which investors should monitor. The company also reported a robust backlog and book-to-bill ratio, indicating continued operational strength.
At the time of this filing, ATRO was trading at $79.42 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $2.8B. The 52-week trading range was $27.27 to $83.96. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.